dc.contributor.author
Lopez, Angela
dc.contributor.author
Dentamaro, Ilaria
dc.contributor.author
Galian, Laura
dc.contributor.author
Calvo, Francisco
dc.contributor.author
Alegret, Josep M
dc.contributor.author
Sanchez, Violeta
dc.contributor.author
Citro, Rodolfo
dc.contributor.author
Moreo, Antonella
dc.contributor.author
Chirillo, Fabio
dc.contributor.author
Colonna, Paolo
dc.contributor.author
Carrero, María Celeste
dc.contributor.author
Bossone, Eduardo
dc.contributor.author
Moral Torres, Sergi
dc.contributor.author
Sao-Aviles, Augusto
dc.contributor.author
Gutiérrez, Laura
dc.contributor.author
Teixido-Tura, Gisela
dc.contributor.author
Rodríguez-Palomares, Jose
dc.contributor.author
Evangelista, Arturo
dc.date.accessioned
2026-02-20T06:52:24Z
dc.date.available
2026-02-20T06:52:24Z
dc.date.issued
2021-11-01
dc.identifier
http://hdl.handle.net/10256/28289
dc.identifier.uri
https://hdl.handle.net/10256/28289
dc.description.abstract
Bicuspid aortic valve (BAV) patients are at high risk of developing progressive aortic valve dysfunction and ascending aorta dilation. However, the progression of the disease is not well defined. We aimed to assess mid-long-term aorta dilation and valve dysfunction progression and their predictors. Patients were referred from cardiac outpatient clinics to the echocardiographic laboratories of 10 tertiary hospitals and followed clinically and by echocardiography for > 5 years. Seven hundred and eighteen patients with BAV (median age 47.8 years [IQR 33-62], 69.2% male) were recruited. BAV without raphe was observed in 11.3%. After a median follow-up of 7.2 years [IQR5-8], mean aortic root growth rate was 0.23 & PLUSMN; 0.15 mm/year. On multivariate analysis, rapid aortic root dilation (> 0.35 mm/year) was associated with male sex, hypertension, presence of raphe and aortic regurgitation. Annual ascending aorta growth rate was 0.43 & PLUSMN; 0.32 mm/year. Rapid ascending aorta dilation was related only to hypertension. Variables associated with aortic stenosis and regurgitation progression, adjusted by follow-up time, were presence of raphe, hypertension and dyslipidemia and basal valvular dysfunction, respectively. Intrinsic BAV characteristics and cardiovascular risk factors were associated with aorta dilation and valvular dysfunction progression, taking into account the inherent limitations of our study-design. Strict and early control of cardiovascular risk factors is mandatory in BAV patients
dc.format
application/pdf
dc.relation
info:eu-repo/semantics/altIdentifier/doi/10.3390/jcm10225264
dc.relation
info:eu-repo/semantics/altIdentifier/issn/2077-0383
dc.relation
info:eu-repo/semantics/altIdentifier/eissn/2077-0383
dc.rights
Attribution 4.0 International (CC BY 4.0)
dc.rights
http://creativecommons.org/licenses/by/4.0/deed.ca
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Journal Of Clinical Medicine, 2021, vol. 10, núm. 22, p. 5264
dc.source
Articles publicats (IDIBGI)
dc.subject
bicuspid aortic valve
dc.subject
aortic stenosis
dc.subject
aortic regurgitation
dc.title
Predictors of Ascending Aorta Enlargement and Valvular Dysfunction Progression in Patients with Bicuspid Aortic Valve
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion